Skip to main content
logo
Whole Shine Medical Technology Co., Ltd. (SHE:002622)
China flag China · Delayed Price · Currency is CNY
2.660
+0.030 (1.14%)
Aug 26, 2026, 12:54 PM CST

SHE:002622 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
-101.02-119.42-37.69-94.37-256.79-75.98
Depreciation & Amortization
38.755.0463.6863.6663.3516.06
Other Amortization
22.1518.0814.0513.7510.871.59
Loss (Gain) From Sale of Assets
-0.03-0.710.58-4.22-0.87-0.03
Asset Writedown & Restructuring Costs
13.9514.950.210.121.2914.64
Loss (Gain) From Sale of Investments
44.4240.233.773.61-76.9817.43
Provision & Write-off of Bad Debts
0.8-2.083.362.512.840.63
Other Operating Activities
39.1130.3564.4982.5238.4642.87
Change in Accounts Receivable
40.7515.14-28.0945.65-21.7236.71
Change in Inventory
9.888.2811.39-8.31-2.17-3.98
Change in Accounts Payable
-8.624.555.12-35.02260.07-32.46
Change in Other Net Operating Assets
5.012.42-10.28-3.12.970.64
Operating Cash Flow
104.0466.0192.36137.0232.2518.37
Operating Cash Flow Growth
80.08%-28.53%-32.59%324.94%75.56%-71.89%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-20.62-21.9-13.79-33.63-23.99-5.74
Sale of Property, Plant & Equipment
0.260.260.010.680.210.05
Cash Acquisitions
-----20.69-34.37
Divestitures
---17.611.89-
Investment in Securities
----7494
Other Investing Activities
--0.713.39--
Investing Cash Flow
-20.37-21.64-13.06-11.9541.4253.94

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Long-Term Debt Issued
--78.41790.5-
Long-Term Debt Repaid
--45.74-142.01-93.02-213.23-40.58
Net Debt Issued (Repaid)
-45.74-45.74-63.61-76.02-122.73-40.58
Issuance of Common Stock
8.338.33----
Common Dividends Paid
-11.98-15.07-16.44-25.37-22.64-34.63
Other Financing Activities
-5.25-1.96-9.59-1.260.1
Financing Cash Flow
-54.64-54.43-89.64-101.39-144.1-75.11

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-0-00-0--
Net Cash Flow
29.03-10.06-10.3523.69-70.43-2.8

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
83.4144.1278.57103.48.2612.63
Free Cash Flow Growth
80.34%-43.85%-24.01%1152.17%-34.62%-80.49%
Free Cash Flow Margin
11.86%6.28%9.12%13.66%1.65%7.51%
Free Cash Flow Per Share
0.100.050.090.120.010.01
Levered Free Cash Flow
74.8358.1485.12102.25293.5583.58
Unlevered Free Cash Flow
89.7482.78111.08130.14332.67107.84

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
8.188.868.862.959.935.16
Change in Working Capital
45.9629.57-20.02-0.55230.081.15